Elaine Sale

Chief Operating Officer at Argos Therapeutics, Inc.

Elaine Sale

Elaine Sale

Chief Operating Officer at Argos Therapeutics, Inc.

Overview
Career Highlights

Argos Therapeutics, Inc.

RelSci Relationships

410

Contact Data
Trying to get in touch with Elaine Sale? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Elaine Sale likely has professional access to. A relationship does not necessarily indicate a personal connection.

Venture Partner at Lumira Capital Investment Management, Inc.

Relationship likelihood: Strong

Chief Executive Officer & Director at Novadip Biosciences SA

Relationship likelihood: Strong

General Partner at GeneChem Management, Inc.

Relationship likelihood: Strong

Managing Partner at TVM Capital GmbH

Relationship likelihood: Strong

Former Partner at The Aurora Funds, Inc.

Relationship likelihood: Strong

Vice President, Finance & Chief Accounting Officer at Argos Therapeutics, Inc.

Relationship likelihood: Average

Chief Restructuring Officer at Argos Therapeutics, Inc.

Relationship likelihood: Average

Director Quality Assurance at Argos Therapeutics, Inc.

Relationship likelihood: Average

Chief Financial Officer & Principal Accounting Officer at Liquidia Technologies, Inc.

Relationship likelihood: Average

Adjunct Professor of Business Management & Marketing at The University of North Carolina at Wilmington

Relationship likelihood: Average

Paths to Elaine Sale
Potential Connections via
Relationship Science
You
Elaine Sale
Chief Operating Officer at Argos Therapeutics, Inc.
Career History
Chief Operating Officer
Tenure Unconfirmed

Argos Therapeutics, Inc. is a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and is headquartered in Durham, NC.

Other Affiliations

Elaine Sale is affiliated with Argos Therapeutics, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Elaine Sale. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Elaine Sale's profile does not indicate a business or promotional relationship of any kind between RelSci and Elaine Sale.